Dendritic cell-based cancer immunotherapy
EG Engleman - Seminars in oncology, 2003 - Elsevier
… These studies show that antigen-loaded dendritic cell vaccinations are safe and promising
in the treatment of cancer. This review discusses the use of dendritic cells in immunotherapy …
in the treatment of cancer. This review discusses the use of dendritic cells in immunotherapy …
Dendritic cells treated with resveratrol during differentiation from monocytes gain substantial tolerogenic properties upon activation
U Švajger, N Obermajer, M Jeras - Immunology, 2010 - Wiley Online Library
… Dendritic cells (DCs) are a functionally diverse cell type and represent the most potent
antigen-presenting cells of the … Resveratrol treatment generates dendritic cells (DCs) capable of …
antigen-presenting cells of the … Resveratrol treatment generates dendritic cells (DCs) capable of …
Prednisolone treatment induces tolerogenic dendritic cells and a regulatory milieu in myasthenia gravis patients
C Luther, E Adamopoulou, C Stoeckle… - The Journal of …, 2009 - journals.aai.org
… Indeed, prednisolone treatment prevents LPS-induced maturation of monocyte-derived dendritic
cells by … In addition, CD4 + T cells cultured in the presence of such tolerogenic dendritic …
cells by … In addition, CD4 + T cells cultured in the presence of such tolerogenic dendritic …
Effectiveness and safety of chemotherapy combined with cytokine-induced killer cell/dendritic cell–cytokine-induced killer cell therapy for treatment of gastric cancer in …
Y Mu, CH Zhou, SF Chen, J Ding, YX Zhang, YP Yang… - Cytotherapy, 2016 - Elsevier
… -induced killer cells (CIKs) [10] and other immune cells, provides a new approach for
cancer treatment, considered as fourth-line cancer therapy [11], [12]. CIKs or dendritic cells (DCs) …
cancer treatment, considered as fourth-line cancer therapy [11], [12]. CIKs or dendritic cells (DCs) …
Tolerogenic dendritic cells
MC Takenaka, FJ Quintana - Seminars in immunopathology, 2017 - Springer
… Dendritic cells (DCs) are pivotal regulators of the immune response, specialized in antigen
presentation to drive T cell … development of novel strategies for the treatment of autoimmunity. …
presentation to drive T cell … development of novel strategies for the treatment of autoimmunity. …
Pharmacological induction of tolerogenic dendritic cells and regulatory T cells
L Adorini, N Giarratana, G Penna - Seminars in immunology, 2004 - Elsevier
… CD25 + Treg cells able to inhibit the T-cell response to a … T cells are also induced by
treatment of adult non-obese … This treatment arrests insulitis, blocks the progression of Th1 cell …
treatment of adult non-obese … This treatment arrests insulitis, blocks the progression of Th1 cell …
Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot study
H Ardon, S Van Gool, IS Lopes, W Maes, R Sciot… - Journal of neuro …, 2010 - Springer
… We integrated immunotherapy in the primary standard treatment for eight pilot adult patients
… lysate-loaded monocyte-derived dendritic cells were given after radiochemotherapy. Boost …
… lysate-loaded monocyte-derived dendritic cells were given after radiochemotherapy. Boost …
Dendritic cells: emerging pharmacological targets of immunosuppressive drugs
H Hackstein, AW Thomson - Nature Reviews Immunology, 2004 - nature.com
… of dendritic cells (DCs). Here, we review our present understanding of how classical and
new immunosuppressive agents interfere with DC development and function. This knowledge …
new immunosuppressive agents interfere with DC development and function. This knowledge …
… the rapid differentiation of monocytes from patients with chronic myeloid leukemia into activated dendritic cells tuned to undergo full maturation after LPS treatment
L Gabriele, P Borghi, C Rozera, P Sestili, M Andreotti… - Blood, 2004 - ashpublications.org
… and activity of monocyte-derived dendritic cells (DCs) from CML patients as well as in
modulation of the cell response to lipopolysaccharide (LPS). Treatment of CML monocytes with IFN…
modulation of the cell response to lipopolysaccharide (LPS). Treatment of CML monocytes with IFN…
Dendritic cell-based vaccines: barriers and opportunities
JA Cintolo, J Datta, SJ Mathew, BJ Czerniecki - Future oncology, 2012 - Taylor & Francis
… Dendritic cells (DCs) have several characteristics that make them an ideal vehicle for tumor
vaccines, and with the first US FDA-approved DC-based vaccine in use for the treatment of …
vaccines, and with the first US FDA-approved DC-based vaccine in use for the treatment of …